| Managing contraception and pregnancy in the rheumatologic diseases. | |
| | |
MedLine Citation:
|
PMID: 20534371 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Most pregnancies in women with rheumatologic disease will result in the delivery of a healthy baby. Pregnancy can be particularly risky in women with active disease or on teratogenic medications, making contraception an important issue for these women. All women with rheumatologic disease have contraceptive options, including barrier methods, the intra-uterine device and progesterone-only medications. Active inflammatory disease, whether in the form of lupus, systemic vasculitis or myositis, places the pregnancy at increased risk. Pre-eclampsia is a particular risk for women with lupus or antiphospholipid syndrome and may be decreased by daily low-dose aspirin. Rheumatoid arthritis typically improves and does not have a major impact on pregnancy outcomes. The expected post-partum arthritis flare may be avoided by restarting medications soon after delivery. Judicious use of medication and close observation may be the keys to successful pregnancy in women with rheumatologic disease. |
| | |
Authors:
|
Megan E B Clowse |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Best practice & research. Clinical rheumatology Volume: 24 ISSN: 1532-1770 ISO Abbreviation: Best Pract Res Clin Rheumatol Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-06-10 Completed Date: 2010-09-16 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101121149 Medline TA: Best Pract Res Clin Rheumatol Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 373-85 Citation Subset: IM |
Copyright Information:
|
Copyright 2009 Elsevier Ltd. All rights reserved. |
Affiliation:
|
Department of Rheumatology & Immunology Duke University Health System, Durham, UK. Megan.clowse@duke.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antiphospholipid Syndrome / complications, drug therapy Antirheumatic Agents / therapeutic use Arthritis, Rheumatoid / complications, drug therapy Contraception / methods* Female Humans Lupus Erythematosus, Systemic / complications, drug therapy Myositis / complications, drug therapy Pregnancy Pregnancy Complications* Pregnancy Outcome* Rheumatic Diseases / complications*, diagnosis, drug therapy Scleroderma, Limited / complications, drug therapy Vasculitis / complications, drug therapy |
| Chemical | |
Reg. No./Substance:
|
0/Antirheumatic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Can we stop progression of ankylosing spondylitis?
Next Document: Evidence-based management of rapidly progressing systemic sclerosis.